Home
>
Newsletter
>
3 Stem Cell Patents Issued Last Week
StemCellPatents.com Newsletter
Your weekly source for the latest stem cell research and stem cell patents.
Dear manoj kumar valluru,
Last week 3 patents of relevance to the area of stem cells were issued.
# 7,361,336 (Patent Spotlight), how to target cancer stem lines using antibodies to frizzled. This may be where the cancer stem cell company Stemline got their name from.
# 7,361,505 discloses a new neural progenitor population.
# 7,361,506 how to treat Parkinson's with melanocyte implants.
This patent covers a new method of cloning cows. Specifically, the patent teaches a method of making a cow blastocyst by
- extracting a primordial gamete cell population from the cow fetus - using the nucleus of the primordial gamete cell as a nuclear donor for an enucleated oocyte - and activating the combination of the...
It was previously reported by the company Medistem (mdsm.ob) that a population of multipotent stem cells exist in menstrual blood. These cells, which Medistem termed "endometrial regenerative cells" appear to possess some of the properties of mesenchymal stem cells, such as...